Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Elanco Animal Health Inc publishes a filing, an earnings call transcript or a press release.
Get ELAN alertsTodd Young is recorded as CFO at Elanco Animal Health Inc (ELAN). The proxy statement of Elanco Animal Health Inc reports total compensation of $4,754,889 for Todd Young in fiscal 2025, including a base salary of $477,096. Disclosed compensation is on record for 7 fiscal years. Todd Young has spoken on 16 earnings calls across 1 company, most recently for Elanco Animal Health Inc on May 7, 2025. Elanco Animal Health Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Elanco Animal Health Inc includes Jeffrey N. Simmons (CEO and Board Member), Jeffrey Simmons (CEO and Board Member), Robert (Bob) VanHimbergen (CFO) and 7 others.
“Today, I will focus my comments on our first quarter adjusted measures, so please refer to today's earnings press release for a detailed description of the year-over-year changes in our reported results.”
“I'll focus my comments on our adjusted measures, so please refer to today's earnings press release for a detailed description of the year-over-year changes in our reported results.”
“Today, I'll focus my comments on our third quarter adjusted measures, so please refer to today's earnings press release for a detailed description of the year-over-year changes in our reported results.”
“Today, I will focus my comments on our second quarter adjusted measures, so please refer to today's earnings press release for a detailed description of the year-over-year changes in our reported results.”
“Today, I will focus my comments on our first quarter adjusted measures, so please refer to today's earnings press release for a detailed description of the year-over-year changes and our reported results.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Elanco Animal Health Inc (ELAN) | Former Executive Vice President and Chief Financial Officer | $477,096 | $4,754,889 |
| 2024 | Elanco Animal Health Inc (ELAN) | Executive Vice President and Chief Financial Officer | $694,000 | $4,109,361 |
| 2023 | Elanco Animal Health Inc (ELAN) | Executive Vice President and Chief Financial Officer | $661,400 | $3,726,720 |
| 2022 | Elanco Animal Health Inc (ELAN) | Executive Vice President and Chief Financial Officer | $639,000 | $3,654,484 |
| 2021 | Elanco Animal Health Inc (ELAN) | Executive Vice President and Chief Financial Officer | $580,000 | $3,291,910 |
| 2020 | Elanco Animal Health Inc (ELAN) | Executive Vice President and Chief Financial Officer | $568,000 | $2,583,940 |
| 2019 | Elanco Animal Health Inc (ELAN) | Executive Vice President and Chief Financial Officer | $550,000 | $2,274,132 |